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Abstract
Background: The aim of the study was to analyse intraoral neurophysiological changes in patients with unilateral
lingual nerve lesions as well as patients with Burning Mouth Syndrome (BMS) by applying a standardized
Quantitative Sensory Testing (QST) protocol.
Methods: The study included patients suffering from a peripheral lesion of the lingual nerve (n = 4), from BMS
(n = 5) and healthy controls (n = 8). Neurophysiological tests were performed in the innervation areas of the
tongue bilaterally. For BMS patients the dorsal foot area was used as reference.
Results: For patients with peripheral lesion of the lingual nerve the affected side of the tongue showed increased
thresholds for thermal (p < 0.05–0.001) and mechanical (p < 0.01–0.001) QST parameters, indicating a hypoesthesia
and thermal hypofunction. In BMS patients, a pinprick hypoalgesia (p < 0.001), a cold hyperalgesia (p < 0.01) and
cold/warmth hypoesthesia (p < 0.01) could be detected.
Conclusions: The results of this study verified the lingual nerve lesion in our patients as a peripheral dysfunction.
The profile showed a loss of sensory function for small and large fibre mediated stimuli. A more differentiated
classification of the lingual nerve injury was possible with QST, regarding profile, type and severity of the neurologic
lesion. BMS could be seen as neuropathy with variable central and peripheral contributions among individuals
resulting in chronic pain.
Keywords: Lingual nerve impairment, Quantitative Sensory Testing, Burning mouth syndrome, Neurosensory
disturbances
Background
Temporary or permanent inferior alveolar nerve injury
(IANI) or lingual nerve impairment (LNI) are well-
recognized complications of oral and maxillofacial surgery
procedures [1–5]. A loss of sensory function in lower lip,
chin and tongue may be a result, which could compromise
talking, drinking and eating [6]. LNI may cause speech
problems [7, 8].
Trigeminal nerve injury is complex [9]. Most nerves
with axonal damage recover incompletely one year after
damage due to surgery [10]. Ischemia or compression
may cause demyelisation of the nerve impairing signal
conduction in the affected nerve fiber [11]. Previous
studies proved that trigeminal nerve damage may also
lead to chronic neuropathic pain syndromes [12–15]. In
the field of oral surgery, IANI and LNI consecutively
cause litigation and patient complaints [16]. Underlying
pathophysiologic mechanisms are still under investiga-
tion and sufficient diagnostic and treatment modalities
are needed urgently [9]. Third molar removal caused
73% of all documented LNI’s [8]. LNI can be due to dir-
ect needle trauma to the fascicles caused by local
anesthetic injection (17%) or causing hemorrhage within
the epineurium or a neurotoxic effect of the anesthetic
agens [9, 17, 18]. Beside this, a possible reason for injury
to the lingual nerve is slitting of the submandibular duct,
which was reported in 2.4% of all cases [19].* Correspondence: amelyhartmann@web.de1Private Practice Dr. Seiler und Kollegen, Echterdinger Str. 7, 70794
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IANI was caused by more diverse procedures includ-
ing third molar removal (60%), local anesthesia (19%),
implants (18%) and endodontics (8%) [8].
Burning mouth syndrome (BMS) is an intraoral chronic
pain condition with an intra-oral burning sensation of the
mucosa [20–22]. According to the International Headache
Society, BMS is defined as “an intra-oral burning or dyses-
thetic sensation, recurring daily for more than 2 h for
more than 3 months, without clinically evident causative
lesions” [23]. The International Association for the Study
of Pain described BMS as “burning pain of the tongue
and/or other oral mucous membrane in the absence of
clinical signs or laboratory findings” [24]. Currently, the
prevalence of BMS in the general population is estimated
to be 0.7 to 15% [25]. BMS occurs without clinical muco-
sal abnormalities or lesions and without any other local or
systemic reasons.
Both pathogenic profiles still represent challenges in
daily practice and the underlying neuropathic mechanism
is not fully understood yet.
The aim of this prospective clinical study was to profile
the neurophysiological changes according to lingual nerve
injury after oral surgery treatment and BMS in order to
present a sufficient screening technique to objectify
intraoral neurological deficiencies. A comparison of
neurophysiological pathways should be derived.
Methods
This prospective clinical monocenter study was in ac-
cordance with the 1964 Declaration of Helsinki on med-
ical protocol and ethics. Ethical approval was permitted
by the local ethics committee of Rhineland-Palatinate
(837.168.13 (8853)). Informed consent of all patients and
volunteers was mandatory.
Study population
All patients were recruited by the same trained examiner
(MD). BMS patients were recruited in accordance with
the IHS criteria for BMS [25, 26]. All of them had a
burning sensation over the tongue. Systemic diseases as
well as local irritations were excluded previous to mea-
surements. LNI patients were included presenting lin-
gual nerve impairment after maxillofacial and dental
surgery more than one year ago. Reasons for impairment
were local anaesthetic injection, multiple surgery after
recurrence of a peripheral giant cell granuloma, tumour
surgery and other dental treatment. Diagnosis was set in
accordance with the IHS.
Healthy volunteers
Oral sensory functions were evaluated by psychophys-
ical means in eight healthy feminine volunteers (age range
between 37 and 69 years, mean 56.9 years ±13,02). Exclu-
sion criteria were previous orofacial injuries, diabetes,
neurological and psychiatric history as well as medication
within 48 h. Two volunteers took regular pain medication
against headache. They were advised to stop medication
48 h prior to QST.
These healthy volunteers were compared to group A
and B.
Group A
Four feminine patients with peripheral injury of the
lingual nerve were included in the study group A (range
of age 39 to 72 years; mean 50.5 years ±14,9). Patients
underwent standardized testing procedures and were ex-
amined by one investigator (RS). Three patients suffered
from a trauma of the LN on the right side, one patient
showed nerve impairment on the left side. One patient
suffering from trauma on the right side took pain killers
and anticonvulsants regularly. She was advised to stop
medication 48 h prior to investigation. QST measure-
ments concerned the innervation areas of the affected
nerves and interindividually compared with the contra-
lateral unaffected side. Patients had to specify the type of
sensory impairment.
Group B
Five patients (4 women, 1 man in the range of age 37 to
70 years; mean 51.8 years ± 12,9) with BMS were analysed
by standardized testing procedures and were examined by
one investigator (MB). The timespan of discomfort ranged
from 14 to 84 months. Two of them took pain killers and
anticonvulsants regularly. They stopped medication 48 h
before measurements. As the whole tongue is affected,
QST measurements were carried out in the anterior part
of the tongue and compared with healthy volunteers.
Additionally, measurements were performed on the dorsal
foot area in each patient to preclude general sensitisation.
Patients had to specify the type of sensory impairment.
Method
The QST protocol used in this study based on the com-
prehensive protocol of the German Research Network
on Neuropathic Pain (DFNS) as described by Rolke et al.
[27] and consisted of the following parameters:
CDT (cold detection threshold); WDT (warm detection
threshold); TSL (thermal sensory limen); PHS (paradoxical
heat sensation); CPT (cold pain threshold); HPT (heat
pain threshold); MDT (mechanical detection threshold);
MPT (mechanical pain threshold); MPS (mechanical pain
sensitivity); DMA (dynamic mechanical allodynia); WUR
(wind up ratio); VDT (vibration detection threshold) and
PPT (pressure pain threshold).
QST was performed in all patients and healthy con-
trols at the Department of Oral Surgery, University
Medical Centre of the Johannes Gutenberg University
of Mainz, Germany. Measurements for one patient took
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about 90 min. In both patient groups, QST evaluated
the left and the right side of the tongue. To standardize
the testing procedure, tests concerned the anterior
third lateral side of the tongue. In patients with BMS,
we used the dorsal area of the foot as control side.
Mechanical and thermal tests were performed accord-
ing to our previous study [28]:
Thermal tests
CDT, TSL, WDT, CPT and HPT were determined by
using a computer-controlled Peltier – type thermode
(stimulation area 9*9 cm2, Somedic® Sales AB, Hörby,
Sweden) and the Classic Method of Limits [29, 30].
Baseline temperature was set to 32 °C and temperature
modulation was performed between 5 and 50 °C. CDT
and WDT represent temperature difference from 32 °C
non-noxious to warm or cold. The first painful cold
(CPT) or hot (HPT) sensation was measured and TSL
was determined by alternating warm and cold stimuli.
Possible PHS was requested as a subjective feeling of
heat upon cooling.
The investigators instructed the patients to press a but-
ton as soon as they noticed the required sensation. Pa-
tients and healthy volunteers had to keep the eyes closed
during the whole QST procedure. Three repetitive mea-
surements reduced bias and thresholds were marked as
mean thresholds.
Mechanical tests
MDT was investigated with a standardized set of modi-
fied von Frey filaments (Optihair2®-Set, Marstock
Nervtest, Germany) and using the “Method of Limits”
with forces between 0.25 and 512 mN graded by a fac-
tor of 2 (1–2 s contact time). The contact area of the
von Frey filaments with the tongue was of uniform size
and shape (rounded tip, 0.5 mm in diameter).
For MPT, custom-made weighted pinprick stimuli
with a flat contact area of 0.25 diameter were used. Fixed
stimulus intensities with forces of 8, 16, 32, 64, 128, 256
and 512 mN were applied at a rate of 2 s on, 2 s off
again in a series of ascending and descending force
intensities. Cut-off was the first sensation of sharpness
appeared or disappeared. Five repetitive measurements
were performed for MDT and MPT and calculation
meant the geometric mean of these 5 series.
Rating pain intensity was evaluated for each stimulus
on a ‘0–100’ scale (‘0’ indicating “no pain” and ‘100’ indi-
cating “maximum imaginable pain”), MPS was measured
using pinprick stimuli and calculated as the geometric
mean of all numerical ratings. Soft stimuli with a cotton
wisp exerting a force of ~5 mN, a cotton wool tip fixed
to an elastic strip (~100 mN) and a cotton wool tip fixed
to a stiff strip (~200–400 mN) indicated DMA. Stimuli
were applied with a single stroke of approximately 1 cm
in length over the tongue at each site and inserted into
the protocol of the pinprick stimuli. Patients and
healthy volunteers gave numerical pain ratings for
each stimulus, given in runs of 10 in pseudorando-
mized sequence in a ~10 s inter-stimulus interval.
Allodynia was calculated as the geometric mean of nu-
merical ratings across the three different types of light
touch stimulators.
WUR was evaluated by applying repeated painful stimuli
(single pinprick stimulus 128mN compared to a series of
10 repetitive pinprick stimuli of same intensity).
The subject was asked to give a pain rating represent-
ing the single stimulus and the estimated mean over the
whole series of 10 stimuli using a ‘0–100’ numerical rat-
ing scale. The whole procedure was repeated five times.
WUR was calculated as the ratio: mean rating of the five
series divided by the mean rating of the five single stim-
uli. VDT was investigated by applying a Rydel–Seiffer
(Aesculap, Tuttlingen, Germany) graded tuning fork
(64 Hz, 8/8 scale) over the tongue in three stimulus rep-
etitions. Individuals had to notice disappearance of the
vibration sensation. Within three series of ascending
stimulus intensities, PPT was measured as the first pain-
ful sensation. The applied pressure gauge device with a
probe diameter of 1.1 cm, FDN200, Wagner Instru-
ments, USA) exerted forces up to 20 kg/cm2 (~2000
kPa) with an increasing ramp of 50 kPa/s per series
(0.5 kg/cm2 per second).
Data evaluation
Data evaluation was performed as described in the stan-
dardized protocol of the German Research Network on
Neuropathic Pain [27, 31]. All statistical calculations
were measured using Statistica® software for Windows
(StatSoft® Inc., USA) and presented as mean ± standard
deviation (SD).
For comparison of differences between Z-score QST
data (patient groups/ controls) two-way analysis of vari-
ance (ANOVA) was used. LSD-post hoc tests (LSD; least
significant difference) was performed to evaluate post
hoc comparisons. In case of missing dynamic mechan-
ical allodynia (DMA) healthy controls, raw data were
tested using unpaired t-test in comparison to the ex-
pected value of zero.
Results of the control group were used to normalize
test results visualized by calculating the z-transform:
Z = (value (patient) – mean (controls)) / SD (controls).
To compare reference data between left and right,
QST data were estimated by subtraction of the left-
tongue side from the right-tongue side respectively. In
case of an estimated mean right–left zero value, the
95% confidence interval of relative reference data was
calculated as zero ±1.96 SD.
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Results
Demographics
QST protocol was used for assessment of sensory pa-
rameters in subjects with LNI (n = 4, Group A), BMS (n
= 5, Group B) and controls (n = 8). 8 (89%) patients were
female and compared to 8 healthy female volunteers
with a mean age of 56.9 years ±13,02 (age range between
37 and 69 years). Study group A consisted of 4 women
with a mean age of 50.5 years ±14,9 (range of age 39 to
72 years). Study group B consisted of 4 women and 1
man with a mean age of 51.8 years ±12,9 (range of age
37 to 70 years).
The mean duration of symptoms experienced by the
LNI group was longer at 58.5 months compared with
the BMS patients who had to cope with their symptoms
for a mean duration of 22.8 months. The timespan of
discomfort in LNI group ranged from 24 to 102 months
and in BMS group from 12 to 42 months.
QST measurements
– LNI patients affected side compared to healthy
controls (group difference) (Table 1 and 2, Fig. 1)
Table 1 Quantitative sensory testing results in patients with lingual nerve impairment (LNI) - Data presented patients’ affected and non-
affected sides as well as controls’ left and right side of the tongue
QST parameter
Log-transformed dataa
Patients (tongue sides) Controls (tongue side)
Affected Contralateral Right Left
CDT (°C) 1.2 ± 0.3 0.5 ± 0.2 0.6 ± 0.1 0.6 ± 0.1
WDT (°C) 1.2 ± 0.2 0.8 ± 0.3 0.7 ± 0.2 0.7 ± 0.2
TSL (°C) 1.5 ± 0.2 1.1 ± 0.2 1.1 ± 0.1 1.1 ± 0.1
CPT (°C)
HPT (°C)
PPT (kPa) 2.3 ± 0.2 2.0 ± 0.1 2.2 ± 0.1 2.2 ± 0.1
MPT (mN) 2.5 ± 0.3 1.7 ± 0.3 1.5 ± 0.2 1.5 ± 0.2
MPS (rating 0–100) −0.6 ± 0.2 0.04 ± 0.1 0.4 ± 0.2 0.4 ± 0.2
WUR (ratio) 0.5 ± 0.4 0.3 ± 0.1 0.2 ± 0.2 0.2 ± 0.2
MDT (mN) 0.7 ± 1.2 −0.3 ± 0.4 −0.7 ± 0.1 −0.6 ± 0.1
VDT (x/8)
Data in original unitsa, b
Patients (tongue sides) Controls (tongue side)
Affected Contralateral Right Left
CDT (°C) −15.7 −3.4 −4.1 −4
WDT (°C) 14.8 6.3 5.4 5.4
TSL (°C) 29.2 12.5 14 13.9
CPT (°C) 5 (cut off) ± 0 10.5 ± 8.5 6.6 ± 0.8 6.4 ± 0.7
HPT (°C) 50 ± 0 48.4 ± 2.1 46.9 ± 1.7 47 ± 1.6
PPT (kPa) 186.2 108.3 142.8 141.4
MPT (mN) 279.2 44.5 30.7 30.9
MPS (rating 0–100) 0.2 1.1 2.6 2.6
WUR (ratio) 3.1 2.1 1.5 1.5
MDT (mN) 5.5 0.5 0.2 0.2
VDT (x/8) 3.8 ± 2.6 5.4 ± 1.1 5.6 ± 0.4 5.8 ± 0.5
aFor CDT and WDT, differences from baseline-temperature (32 °C) are shown
bRetransformed mean for log-normally distributed data. All data are presented as mean ± SD. In the case of CPT, HPT and VDT, mean original data ± SD are shown.
There is no evidence of occurrence of DMA and PHS
CDT Cold detection threshold, WDT Warm detection threshold, TSL Thermal sensory limen, CPT Cold pain threshold, HPT Heat pain threshold, PPT Pressure pain
threshold, MPT Mechanical pain threshold, MPS Mechanical pain sensitivity, WUR Wind-up ratio, MDT Mechanical detection threshold, VDT Vibration detection
threshold, DMA Dynamic mechanical allodynia, PHS Paradoxical heat sensation
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Comparing patients’ affected side of the tongue with
healthy volunteers a significant difference in the percep-
tion was evaluated for several QST parameters. Com-
pared to controls, the affected side showed a significant
thermal hypoesthesia represented by CDT p < 0.001
WDT p < 0.05 and TSL p < 0.001 and a significant thermal
hypoalgesia represented by HPT p < 0.05 on the side with
the lesion. For mechanical parameters, significant diversity
was found for MPT (p < 0.001), MPS (p < 0.001) and
MDT (p < 0.01). No PHS occurred and no significant
DMA was found. For WUR, VDT and PPT showed no sig-
nificant difference compared to healthy control side.
– LNI patients affected side compared to contralateral
control side (side difference) (Tables 1 and 2, Fig. 1)
Comparing the testing areas (right and left side of the
tongue) almost all QST parameters showed significant dif-
ferences (CDT p < 0.001, WDT p < 0.001, TSL p < 0.01 CPT
p < 0.05, HPT p < 0.01, MDT p > 0.01, MPT p < 0.001, MPS
p < 0.001, PPT p < 0.01, VDT p > 0.05). Exceptions were
WUR and DMA. These parameters showed no significant
loss of function when comparing healthy and affected side.
– LNI patients affected side compared to contralateral
and healthy control group (interaction group/side)
(Table 2)
Comparing affected sides with contralateral and healthy
control group, significant difference comparable to inter-
individual tests were measured.
– BMS patients tongue compared to healthy controls
tongue (group difference) (Tables 3 and 4, Fig. 2)
Comparing patients’ tongue with healthy control sub-
jects a significant difference in the perception was found
for several QST parameters. In BMS patients, we mea-
sured for the tongue a deficiency in cold-perception (CDT
p < 0.01). Regarding WDT, the difference in BMS-patients
was significant (p < 0.01) at the tongue compared to the
control group. Furthermore, we found a severe mechan-
ical hypoesthesia at the tongue (MPT p < 0.001). A signifi-
cant cold hyperalgesia (CPT p < 0.01) was detected at the
tongue.
– BMS patients tongue compared to foot in BMS
patients (area difference) (Tables 3 and 4, Fig. 2)
In addition, only slight differences for CDT p < 0.05
and PPT p > 0.05 were found for the patient’s feet
compared to the control group. There was no statistical
difference between the two groups for HPT, MPS, WUR,
MDT and VDT at the tongue not the foot. No PHS
occurred.
Table 2 Comparison of the QST parameters in patients with lingual nerve impairment (LNI) (Results of the ANOVA – LSD posthoc
analysis)
1) Group difference 2) Side-difference 3) Interaction group/side
LNI versus control group LNI versus uninjured side
ANOVA Factor LSD posthoc ANOVA Factor LSD posthoc ANOVA Factor LSD posthoc
QST Parameter F-value P-value F-value P-value F-value P-value
CDT 11 <0.01 ** <0.001 *** 42.2 <0.001 *** <0.001 *** 39.3 <0.001 *** <0.001 ***
WDT 3.9 n.s. <0.05 * 18 <0.01 ** <0.001 *** 17.6 <0.01 ** <0.01 **
TSL 7.1 <0.05 * <0.001 *** 11.6 <0.01 ** <0.01 * 11.2 <0.01 ** <0.001 ***
CPT 0.8 n.s. n.s. 3.5 n.s. <0.05 * 4 n.s. n.s.
HPT 5.5 <0.05 * <0.05 * 5.9 <0.05 * <0.01 ** 7.6 <0.05 * <0.01 **
PPT 0 n.s. n.s. 8.3 <0.05 * <0.01 ** 7.7 <0.05 * n.s.
MPT 36.8 <0.001 *** <0.001 *** 20.4 <0.001 *** <0.001 *** 20.8 <0.001 *** <0.001 ***
MPS 58.9 <0.001 *** <0.001 *** 483.3 <0.001 *** <0.001 *** 492.4 <0.001 *** <0.001 ***
WUR 4.5 n.s. n.s. 2.4 n.s. n.s. 2.3 n.s. <0.05 *
MDT 11.9 <0.01 ** <0.01 ** 7.9 <0.05 * <0.01 ** 8.7 <0.05 * <0.001 ***
VDT 3.2 n.s. n.s. 6.7 <0.05 * <0.05 * 4.5 n.s. <0.05 *
DMA 2.8 n.s. n.s. 0.1 n.s. n.s. 0.3 n.s. n.s.
1) LNI patients affected side compared to healthy controls (group difference)
2) LNI patients affected side compared to contralateral control side (side difference)
3) LNI patients affected side compared to contralateral and healthy control group (interaction group/side)
QST was performed as a split study on the left and right side of the tongue on patients (n = 4) and healthy controls (n = 8). An ANOVA as well as a LSD posthoc
(groups/ side/ interaction) was calculated to indicate main effects in the comparison of the LNI and the control group (group difference), the LNI and uninjured
side of the tongue (side-difference) and for the interaction among each other (interaction group/side) *p < 0.05; **p < 0.01, ***p < 0.001; n.s. = no significance,
significance shown in Fig. 1
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– BMS patients tongue compared to foot and
healthy control group (interaction group/area)
(Tables 3 and 4, Fig. 2)
Comparing patients’ foot and tongue with healthy
control group LSD post hoc showed no significance.
– Contralateral uninjured side of the LNI patients
compared with controls (Table 1 Fig. 1)
In one patient, we expired cold hyperalgesia on the
uninjured side. Concerning other QST parameter, LNI
uninjured contralateral side didn’t distinguish from
healthy controls. Only for PPT, contralateral uninjured
side of the LNI patient group seems to be more sensitive
than the control group.
Discussion
The original contribution of this study was to describe
and objectify intraoral neurophysiological changes in pa-
tients suffering from LNI and patients with an idiopathic
BMS. Therefore, we used a standardized QST protocol.
LNI group (A)
Patients with an LNI clinically revealed a profound
hypoesthesia. All of them were proved to have a re-
duced thermal and mechanical sensibility compared to
the control group and compared to the contralateral
side as well. This is in accordance with Yilmaz et al.
[32] who reported a significant decreased sensitivity to
cool temperature and also to warm stimuli on the injured
side compared to control side. They also described a cold
and heat hypoalgesia on the injured and non-injured side.
The type of injury such as local anesthetic injection,
dental treatment, tumor surgery or surgery after recur-
rence of a peripheral giant cell granuloma did not influ-
ence testing results.
Thermal tests included detection and pain thresholds
for warmth, hot and cold sensations representing C-
and A-delta fiber mediated stimuli [27, 31]. All thermal
tests showed significantly altered thresholds compared
to control side and also to healthy individuals as an
expression of a sensory deficit of the lingual nerve.
According to these results a deficit of these fibers can
be assumed. This was also described by Renton et al.
[29], who investigated a reduced sensitivity of the in-
jured side of the tongue to hot and cold stimuli. In their
study, sensitivity on cold thresholds proved to be higher
than on warm thresholds. This is in line with previous
literature (Green 1984 [33] and 1987 [34]) and also
confirms results of our study in which the cold detec-
tion thresholds were increased significantly compared
to the contralateral side. This significantly increased
threshold for detection of cold stimuli in the affected
Fig. 1 Z-score QST profiles of the tongue in patients with LNI. A Z-score of 0 means the score is the same as for the mean of the healthy subjects.
It can also be negative or positive indicating loss or gain of function. Affected side (filled-circles) represent the QST profiles of all patient’s affected
tongue sides suffering from a peripheral lesion of the lingual nerve. The profile shows a combined loss of sensory function for small fiber mediated
stimuli and for large fiber mediated stimuli (note the mechanical detection threshold for von Frey-filaments (MDT), and the vibration detection
threshold (VDT). Contralateral (open circles) show the QST profile of all patient’s healthy sides of the tongue. Z-Score range represents physiologic
values of healthy volunteers. *p < 0.05; **p < 0.01, ***p < 0.001; n.s. = no significance
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area indicates a decreased function of slightly myelin-
ated A-delta fibers [31, 35, 36].
Jääskeläinen et al. [37] already reported long-lasting
thermal hypoesthesia after unilateral nerve injury. They
pointed out that thermal hypoesthesia or anesthesia rec-
ognized by the patient is characteristic for peripheral
nerve injury, as seen in patients of this study.
Small, unmyelinated C-fibers were represented by the
WDT and HPT. After an oral surgical treatment, WDT
was shown to improve more slowly than the other tests
[16]. This may proof damage to C-fibers as a negative
prognostic factor [16]. Since the thermal thresholds for
warm were also increased, it is to assume that damage
or violation of unmyelinated C-fibers might also be in-
volved in our patients. As a consequence, peripheral
nerve damage was investigated and thermal hypoesthesia
[30] and hypoalgesia could be assumed which is in line
with Yilmaz et al. [32] who also proofed a cold and heat
hypoalgesia in a much larger sample size.
In one LNI patient we even found cold hyperalgesia
on the uninjured contralateral side as seen in the per-
formed z-score analysis. However, further investigations
showed no deviations in all other assessments and were
similar to healthy controls.
These findings were in accordance with results of the
mechanical tests. Mechanical pain thresholds are more
suitable to detect sensory plus and minus signs [14, 16].
Affected sides of the tongue presented significantly in-
creased PPT thresholds (C- and A-delta fiber mediated),
MPT, MDT and MPS (all A-delta fiber mediated stimuli)
and VDT compared to contralateral, unaffected side.
VDT was significantly increased comparing the affected
side of the tongue with the unaffected side, indicating
damage in A-beta fibers [31, 35]. Except for PPT and
VDT increased thresholds were also found comparing
patients with healthy subjects. Maybe due to small sam-
ple size, there was no significant difference comparing
the affected side with the volunteers for VDT and PPT.
In ANOVA testing, there was no significant difference
comparing both sides of the tongue, but with LSD post-
hoc test LNI side compared with the volunteers showed
a significant difference for WUR. This demonstrated also
a deficit of A-beta fibers. This pattern of the mechanical
tests showed a deficit of the affected fibers and con-
firmed the results of the thermal tests.
Using QST we were able to demonstrate a sensory def-
icit in all fiber functions, painful and non-painful stimuli
for peripheral LNI. This result is confirmed by other
studies [10, 30, 38, 39]. As a consequence, it is to assume
that patients with LNI suffer from serious axonal injuries
or separations with irreversible sensory disturbances. All
of them are affected by a primary axonotmesis or neu-
rotmesis, caused by extensive damage or destruction of
axons with consecutive decrease in density of all fibers
(A-beta-, A-delta-, C-fibers) which explains the sensory
deficits.
BMS group (B)
In the BMS group, CDT and WDT also showed signifi-
cant deficiencies in affected patients indicating a cold/
warmth-hypoesthesia and consecutively a small fiber
Table 3 Quantitative sensory testing results in patients with
burning mouth syndrome (BMS) – Data presented patients





Tongue Foot Tongue Foot
CDT (°C) 0.4 ± 0.2 0.6 ± 0.3 −0.4 ± 0.5 0.3 ± 0.2
WDT (°C 0.5 ± 0.1 0.6 ± 0.2 0.2 ± 0.2 0.6 ± 0.2
TSL (°C) 0.6 ± 0.1 0.9 ± 0.1 0.3 ± 0.3 0.8 ± 0.3
CPT (°C)
HPT (°C)
PPT (kPa) 2.1 ± 0.1 2.7 ± 0.1 2.2 ± 0.1 2.8 ± 0.1
MPT (mN) 1.9 ± 0.3 1.5 ± 0.2 1.5 ± 0.1 1.5 ± 0.1
MPS (rating 0–100) 0.1 ± 0.4 0.2 ± 0.2 0.4 ± 0.2 0.2 ± 0.2
WUR (ratio) 0.3 ± 0.3 0.4 ± 0.3 0.2 ± 0.2 0.3 ± 0.2
MDT (mN) −0.5 ± 0.3 0.2 ± 0.5 −0.7 ± 0.1 0.2 ± 0.3
VDT (x/8)
Data in original unitsa, b
Patients Controls
Tongue Foot Tongue Foot
CDT (°C) −2.39 −4.24 −0.42 −2.19
WDT (°C) 2.96 4.26 1.46 3.90
TSL (°C) 4.06 8.23 1.94 5.61
CPT (°C) 16.11 ± 5.38 13.97 ± 7.94 9.11 ± 1.60 8.35 ± 2.86
HPT (°C) 42.07 ± 2.96 42.87 ± 3.65 44.18 ± 2.14 44.95 ± 1.86
PPT (kPa) 124.5 448.6 150.0 689.33
MPT (mN) 85.62 34.30 29.3 34.08
MPS (rating 0–100) 1.26 1.47 2.65 1.73
WUR (ratio) 1.81 2.43 1.55 1.96
MDT (mN) 0.31 1.58 0.21 1.58
VDT (x/8) 6.07 ± 0.80 6.09 ± 0.86 5.68 ± 0.40 6.62 ± 0.79
aFor CDT and WDT, differences from baseline-temperature (32 °C) are shown
bRetransformed mean for log-normally distributed data. All data are presented
as mean ± SD. In the case of CPT, HPT and VDT, mean original data ± SD are
shown. There is no evidence of occurance of DMA and PHS. In the case of
CPT, HPT and VDT, mean original data are shown. All data are presented as
mean ± SD. There is no evidence of occurrence of DMA and PHS
CDT Cold detection threshold, WDT Warm detection threshold, TSL Thermal
sensory limen, CPT Cold pain threshold, HPT Heat pain threshold, PPT Pressure
pain threshold, MPT Mechanical pain threshold, MPS Mechanical pain sensitivity,
WUR Wind-up ratio, MDT Mechanical detection threshold, VDT Vibration detection
threshold, DMA Dynamic mechanical allodynia, PHS Paradoxical heat sensation
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loss. Yilmaz et al. [32] reported contrary findings. They
proofed BMS patients being significantly more sensitive to
cold and warm stimuli than healthy controls representing
a hyperesthesia. One possible explanation might be a dif-
ferent patient composition which could cause a deviation
of results especially in a limited patient cohort. In general,
results should be interpreted with consideration of the
limitations of the psychophysiological assessment tool
which is highly dependant on patients’ mental abilities
and compliance. Patients may also get tired and distracted.
Table 4 Comparison of the QST parameters in patients with burning mouth syndrome (BMS) (Results of the ANOVA – LSD posthoc analysis)
1) Group difference 2) Area-difference 3) Interaction
group/area
BMS versus control group BMS versus foot
ANOVA Factor LSD posthoc ANOVA Factor LSD posthoc ANOVA Factor LSD posthoc
QST Parameter F-value P-value F-value P-value F-value P-value
CDT 18 <0.001 *** <0.01 ** 0.4 n.s. n.s. 0.4 n.s. <0.01 **
WDT 4.3 n.s. <0.01 ** 7.6 <0.05 * <0.01 ** 7.6 <0.05 * <0.01 **
TSL 2.2 n.s. n.s. 5.8 <0.05 * <0.05 ** 5.8 <0.05 * n.s.
CPT 11.1 <0.01 ** <0.01 ** 2.6 n.s. n.s. 2.6 n.s. <0.05 *
HPT 2.5 n.s. n.s 0 n.s. n.s. 0 n.s. n.s.
PPT 7.8 <0.05 * n.s. 0.2 n.s. n.s. 0.2 n.s. n.s.
MPT 11.3 <0.01 ** <0.001 *** 6.9 <0.05 * <0.01 ** 6.9 <0.05 * <0.001 ***
MPS 1.8 n.s. n.s. 2.8 n.s n.s. 2.8 n.s. <0.05 *
WUR 0.5 n.s. n.s. 0 n.s. n.s. 0 n.s. n.s.
MDT 0.5 n.s n.s. 4.6 <0.05 * <0.05 * 4.6 <0.05 * n.s.
VDT 0.8 n.s. n.s. 2.5 n.s. n.s. 2.5 n.s. n.s.
1) BMS patients’ tongue compared to healthy controls’ tongue (group difference)
2) BMS patients’ tongue compared to foot in BMS patients (area difference)
3) BMS patients’ tongue compared to foot and healthy control group (interaction group/area)
QST was performed as a split study on the tongue and the foot on patients (n = 5) and healthy controls (n = 8). An ANOVA as well as a LSD posthoc
(groups/ area/ interaction) was calculated to indicate main effects in the comparison of the BMS and control group, the tongue and the foot, and for
the interaction among each other (interaction group/ area) *p < 0.05; **p < 0.01, ***p < 0.001; n.s. = no significance, significance shown in Fig. 2
Fig. 2 Z-score QST profiles of the tongue in patients with BMS. A Z-score of 0 means the score is the same as for the mean of the healthy subjects. It
can also be negative or positive indicating loss or gain of function. Filled-circles represent the QST profiles of the tongue for all patient’s suffering from
burning mouth syndrome. Open circles show the QST profile of all patient’s foot. Z-Score range represents physiologic values of healthy volunteers.
The profile shows a predominant small fiber deficit; which is possible a conditioning input to central neurons and thus mediates cold hyperalgesia and
also Pinprick hypoalgesia. For DMA and PHS there was no significant difference. (*p < 0.05, **p < 0.01, ***p < 0.001)
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As reported in this recent study, there is also difficulty in
identification of cases of heat hyperalgesia (possibly due to
adaptation to warming due to the method of limits
(+50 °C cutt-off point). As a possible solution, the
Method of Levels was discussed to avoid tired and
distracted patients and – concerning ethical guidelines –
faster stimulus ramps and suprathresholds.
Evaluating profiles of neuropathic pain states, cold and
warm hypoesthesia is well-known [40] and also found as a
part of trigeminal nerve injury [41]. These peripheral
neurologic changes coexist with other neurophysiological
findings. For the tongue, a significant cold hyperalgesia
was evaluated in CPT pointing to a small fiber neuropathy
with central components. This cold hyperalgesia is a sign
for central sensitization in patients with BMS, which was
not found in patients with LNI. Yilmaz et al. [32] also
documented a cold hyperalgesia compared with control
patients.
A possible mechanism for a central sensitization could
be found in the plasticity of neurons in the posterior
horn of the spinal cord. Another explanation may be a
loss of the central pain inhibition normally performed by
the brain stem, the rostral ventro-medial medulla and
the central gray matter. These results are also in accord-
ance with Lauria et al. [42], who analyzed the tongues of
BMS-patients by histological examination and according
to Forssell et al. [30]. Both studies concluded that BMS
has a neuropathic component. Primary burning mouth
syndrome was also emphasized to be caused by deregu-
lated subclinical neuropathic pain [43].
Mechanical tests (especially MPT) revealed a pinprick-
hypoalgesia indicating an impaired function in small
fibers. As already seen in our LNI patients, this hypo-
function is a typical finding in patients suffering from
peripheral nerve damage. This is in accordance with pre-
viously published results [37].
Comparing measurements of the dorsal foot in affected
patients and healthy control group, all QST parameters
revealed no significant differences. By using the dorsal foot
as reference, a generalized neuropathy could be excluded.
In this study, BMS was evaluated as a localized neur-
opathy with variable central and peripheral contributions
among individuals as already described elsewhere [43].
Profiling patients with LNI and BMS, QST proved to
be a non-invasive, psychophysical approach to profile
thermal and mechanical somatosensation as already
shown in previous studies [16, 27, 30, 44, 45]. Sensory
signs were characterized by QST. They point to possible
neurobiological mechanisms such as central or periph-
eral sensitization (Yekta et al., 2010b, Rolke et al., 2006a,
Rolke et al., 2006b, Said-Yekta et al., 2012, Cruccu et al.,
2004, Renton et al., 2006).
Because of increasing forensic implication in patients’
treatment, QST might be a useful tool to objectify clinical
findings [14]. In affected patients with LNI or BMS, the
monitoring of afferent nerve fiber functions is challenging
and in these cases, QST might help to support decisions
on further interventions. This was already emphasized by
Jaaskelainen et al. [43] who described three distinct
subclinical neuropathic pain states in BMS patients. They
emphasized targeted treatment modalities according to
these subgroups and careful neurophysiologic examina-
tions to distinguish these groups. Also in patients with
iatrogenic nerve lesions, targeted treatment modalities
were presented in previous studies [9, 46]. A proper use of
neurophysiological diagnostic tests seems to offer the pos-
sibility for targeted interventions based one the underlying
pathophysiological mechanisms.
As an alternative to QST, sensory dysfunction in
humans can be objectively quantified by electrophysio-
logical recordings of trigeminal sensory-evoked cortical
potentials [47] and brainstem reflexes [48] after stimu-
lation of extraoral and intraoral sites [44, 49]. Func-
tional magnetic resonance imaging may also reveal
sensory functions [50, 51]. But these methods are com-
plex, and still more time consuming than QST and do
not allow the identification of isolated sensory deficien-
cies and therefore seem not to be appropriate in clinical
routine. The QST protocol used in this study remains
time consuming in clinical routine diagnostic. Some
studies [29, 52] restricted screening to thermal QST to
examine the tongue. By extending the protocol to in-
clude mechanical components however, a differentiated
classification of nerve fiber function is possible. Previ-
ous studies [6, 53] emphasized to reduce the QST bat-
tery to only seven parameters. In order to benefit from
the entire potential of QST based diagnosis, exclusion
of parameters can’t be recommended because essential
information concerning hypo- and hyperesthesia would
be missing.
Conclusions
The present study used the standardized QST battery in
patients with LNI and BMS. Different nerve fiber func-
tions in nine patients with sensory disturbances were
evaluated and compared with healthy controls. Thermal
and mechanical tests allowed an accurate topographical
diagnosis of nerve lesions and a determination of the
profile, type and severity of LNI and BMS patients. QST
seems to offer a valid option to profile somatosensory
nerve fiber function and can be applied for non-invasive
assessment of sensory nerve function.
The results indicate that patients with LNI suffer from
a peripheral neuropathy. The increased thermal and
mechanical thresholds point to a serious axonal injury
or separation and recovery seems to be doubtful. BMS
could be seen as neuropathy with variable central and
peripheral contributions among individuals resulting in
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chronic pain. Targeted therapy options may follow after
neurophysiological diagnosis. This protocol proved to be
suitable to identify and precisely describe peripheral and
central nerve fiber function in the orofacial area.
Abbrevations
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deviation; TSL: Thermal sensory limen; VDT: Vibration detection threshold;
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